Dunstan CR et al. (2007) Therapy Insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease Nat Clin Pract Oncol 4: 42–55 doi:10.1038/ncponc0688

Figure 3 Disease distribution in publications detailing bisphosphonate-related ONJ (derived from data in Table 2)